Eric Martz
Joined 9 October 2007
Eric Martz (talk | contribs) |
Eric Martz (talk | contribs) |
||
| (32 intermediate revisions by the same user not shown) | |||
| Line 93: | Line 93: | ||
*I started a stub for [[Antibody]]. Article later written by [[User:David Canner]] and others. | *I started a stub for [[Antibody]]. Article later written by [[User:David Canner]] and others. | ||
*[[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | *[[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | ||
**[[Proteopedia:Featured SEL/1]] | |||
*[[Drug and peptide transport in humans]] | |||
** [[Proteopedia:Featured EDU/7]] | |||
** [[Proteopedia:Featured EDU/8]] | |||
*[[Flagella, bacterial]] <- [[Flagellum]], [[Flagellar structure]] | *[[Flagella, bacterial]] <- [[Flagellum]], [[Flagellar structure]] | ||
*[[Flagellar filament of bacteria]] | *[[Flagellar filament of bacteria]] | ||
| Line 110: | Line 114: | ||
*[[Recoverin, a calcium-activated myristoyl switch]] | *[[Recoverin, a calcium-activated myristoyl switch]] | ||
*[[Ribosomal A Site Binding Paromomycin: A Morph]] | *[[Ribosomal A Site Binding Paromomycin: A Morph]] | ||
*[[SARS-CoV-2 protein S priming by furin]] | *[[SARS-CoV-2 protein S priming by furin]] | ||
*[[SARS-CoV-2 spike protein fusion transformation]] | **[[Proteopedia:Featured_SEL/5]] | ||
*[[SARS-CoV-2 spike protein mutations]] | *[[SARS-CoV-2 spike protein fusion transformation]] | ||
**[[Proteopedia:Featured_SEL/6]] | |||
*[[SARS-CoV-2 spike protein mutations]] | |||
**[[Proteopedia:Featured_SEL/7]] | |||
*[[Structure of E. coli DnaC helicase loader]] (about a homology model) | *[[Structure of E. coli DnaC helicase loader]] (about a homology model) | ||
*[[SV40 Capsid Simplified]] | *[[SV40 Capsid Simplified]] | ||
*[[Synthetic nanomaterials from standardized protein blocks]] | |||
*[[Thermal motion of peptide]] | *[[Thermal motion of peptide]] | ||
| Line 167: | Line 175: | ||
====A-B==== | ====A-B==== | ||
*[[About Macromolecular Structure]] | *[[About Macromolecular Structure]] | ||
*[[AlphaFold/Index]], a list of Proteopedia pages about AlphaFold. | *[[AlphaFold/Index]], a list of Proteopedia pages about AlphaFold. | ||
*[[AlphaFold]], an introduction and overview. | *[[AlphaFold]], an introduction and overview. | ||
*[[AlphaFold2 examples from CASP 14]] | *[[AlphaFold2 examples from CASP 14]] | ||
*[[How to predict structures with AlphaFold| | *AlphaFold3: | ||
**[[Converting AlphaFold3 CIF to PDB]] | |||
**[[User:Eric Martz/AlphaFold3 case studies]] | |||
*AlphaFold: [[How to predict structures with AlphaFold|How to predict structures from sequences]] | |||
*AlphaFold: [[FirstGlance/How to get average pLDDT from AlphaFold models|How to get average pLDDT]] | |||
*[[Alternate locations]] (initiated by Wayne Decatur) | *[[Alternate locations]] (initiated by Wayne Decatur) | ||
**[[Alternate locations of backbones]] | **[[Alternate locations of backbones]] | ||
| Line 193: | Line 209: | ||
**[[User:Eric_Martz/Cavity_Notes]] | **[[User:Eric_Martz/Cavity_Notes]] | ||
*[[Chain]] <- [[Chains]] | *[[Chains and Chain IDs]] <- [[Chain]] <- [[Chains]] | ||
*[[Clashes]] | *[[Clashes]] | ||
*[[Chimera]] | *[[Chimera]] | ||
| Line 212: | Line 228: | ||
*[[Disulfide bond]] | *[[Disulfide bond]] | ||
*[[Domain]] | *[[Domain]] | ||
*[[Drug and peptide transport in humans]] | |||
*[[DRuMS]] | *[[DRuMS]] | ||
*[[Eric Martz's Favorites]] | *[[Eric Martz's Favorites]] | ||
*[[Electron cryomicroscopy]] | *[[Electron cryomicroscopy]] | ||
*[[Electron density maps]] | *[[Electron density maps]] | ||
*[[Electrostatic potential maps]] | |||
** [[Proteopedia:Featured EDU/6]] | |||
*[[Empirical models]] | *[[Empirical models]] | ||
*[[Epitopes]] | *[[Epitopes]] | ||
| Line 235: | Line 254: | ||
*[[History of Macromolecular Visualization]] | *[[History of Macromolecular Visualization]] | ||
*[[Homology modeling]] | *[[Homology modeling]] | ||
*[[How to find a protein's best structure]] | |||
*[[Practical Guide to Homology Modeling|Homology Modeling, Practical Guide to]] | *[[Practical Guide to Homology Modeling|Homology Modeling, Practical Guide to]] | ||
*[[Homology modeling servers]] | *[[Homology modeling servers]] | ||
| Line 259: | Line 279: | ||
*[[Lysine-cysteine NOS bonds]] <-- [[NOS]] Disambiguation | *[[Lysine-cysteine NOS bonds]] <-- [[NOS]] Disambiguation | ||
*[[Membrane proteins]] | *[[Membrane proteins]] | ||
*[[Missing residues and incomplete sidechains]] | |||
*[[Molecular modeling and visualization software]] | *[[Molecular modeling and visualization software]] | ||
*[[Molecular Playground]] | *[[Molecular Playground]] | ||
| Line 272: | Line 293: | ||
*[[Non-Standard Residues]] | *[[Non-Standard Residues]] | ||
*[[Lysine-cysteine NOS bonds|NOS bonds]] | *[[Lysine-cysteine NOS bonds|NOS bonds]] | ||
*[[Proteopedia:Overview|Overview of Proteopedia]] | |||
*[[PDB identification code]] <- [[PDB code]], [[PDB codes]], [[pdb code]], [[pdb codes]] | *[[PDB identification code]] <- [[PDB code]], [[PDB codes]], [[pdb code]], [[pdb codes]] | ||
*[[Peptide]] (page created by Eran Hodis) | *[[Peptide]] (page created by Eran Hodis) | ||
| Line 284: | Line 306: | ||
**[[Protein primary, secondary, tertiary and quaternary structure (Spanish)|Los cuatro niveles estructurales de las proteínas]] | **[[Protein primary, secondary, tertiary and quaternary structure (Spanish)|Los cuatro niveles estructurales de las proteínas]] | ||
*[[Pyrrolysine]] | *[[Pyrrolysine]] | ||
*[[Quality assessment for molecular models]] | *[[Quality assessment for molecular models]] | ||
*[[R value]] | *[[R value]] | ||
| Line 292: | Line 312: | ||
** See also [[Dihedral/Index]] (initiated by Angel Herráez) | ** See also [[Dihedral/Index]] (initiated by Angel Herráez) | ||
*[[User:Eric Martz/Remarkable Structures|Remarkable Structures]] | *[[User:Eric Martz/Remarkable Structures|Remarkable Structures]] | ||
*[[RMSD]] | |||
*[[Renumbering PDB files]] | *[[Renumbering PDB files]] | ||
*[[Resolution]] | *[[Resolution]] | ||
*[[Retractions and Fraud]] | *[[Retractions and Fraud]] | ||
*[[Ribosomal_A_Site_Binding_Paromomycin:_A_Morph]] | |||
====S-Z==== | ====S-Z==== | ||
| Line 316: | Line 338: | ||
*[[Temperature value vs. resolution]] | *[[Temperature value vs. resolution]] | ||
*[[Temperature color schemes]] | *[[Temperature color schemes]] | ||
*[[Theoretical models]] <- [[Theory]], [[Theoretical model]] | *[[Theoretical models]] <- [[Theory]], [[Theoretical model]] | ||
**[[Proteopedia:Featured_SEL/8]] | |||
*[[Thioester protein cross-links]] | *[[Thioester protein cross-links]] | ||
*[[Thioether protein crosslinks]] | *[[Thioether protein crosslinks]] | ||
*[[Unusual sequence numbering]] | *[[Unusual sequence numbering]] | ||
*[[Van der Waals radii]] | *[[Van der Waals radii]] | ||
*[[FirstGlance/Virus Capsids and Other Large Assemblies|Virus Capsids and Other Large Assemblies]] | |||
** Polio: [[Proteopedia:Featured EDU/4]] | |||
** Eastern Equine Encephalitis virus [[Proteopedia:Featured EDU/5]] | |||
** Bacterial gas vesicles [[Proteopedia:Featured SEL/9]] | |||
*[[Introduction to molecular visualization|Visualization, molecular, introduction to]] | *[[Introduction to molecular visualization|Visualization, molecular, introduction to]] | ||
*[[Water in macromolecular models]] | *[[Water in macromolecular models]] | ||
| Line 342: | Line 369: | ||
===Interactive 3D Complements=== | ===Interactive 3D Complements=== | ||
* [[User:Fadel_A._Samatey/FlhBc_I]] (April, 2013) | * [[User:Fadel_A._Samatey/FlhBc_I]] (April, 2013) | ||
* [[User:Fadel A. Samatey/FlgA I]] (June, 2016) | |||
** [[Proteopedia:Featured JRN/1]] | |||
*[[Malvankar/1]] (March, 2015) | *[[Malvankar/1]] (March, 2015) | ||
** Animations of pilus model: [http://proteopedia.org/wiki/images/b/b5/Geobacter_pilus_assembling_animation.gif Assembly], [http://proteopedia.org/wiki/images/0/0f/Geobacter_pilus_assembled_rocking.gif Rocking], [http://proteopedia.org/wiki/images/0/0a/Geobacter_pilus_aromatics_rotating.gif Aromatics]. | ** Animations of pilus model: [http://proteopedia.org/wiki/images/b/b5/Geobacter_pilus_assembling_animation.gif Assembly], [http://proteopedia.org/wiki/images/0/0f/Geobacter_pilus_assembled_rocking.gif Rocking], [http://proteopedia.org/wiki/images/0/0a/Geobacter_pilus_aromatics_rotating.gif Aromatics]. | ||
*[[Malvankar/2]] (April, 2019) | |||
** [[Proteopedia:Featured JRN/3]] | |||
*[[Malvankar/3]] (September, 2021) | |||
** [[Proteopedia:Featured JRN/4]] | |||
*[[Ke Xiao/1]] (March, 2016) | *[[Ke Xiao/1]] (March, 2016) | ||
| Line 434: | Line 467: | ||
*[[Proteopedia:About]] | *[[Proteopedia:About]] | ||
*[[Proteopedia:Guidelines for Ethical Writing]] was started by Jaime Prilusky. I added the sections on ''Content Attribution'' and ''Images''. | *[[Proteopedia:Guidelines for Ethical Writing]] was started by Jaime Prilusky. I added the sections on ''Content Attribution'' and ''Images''. | ||
*[[Proteopedia:Introduction]] | *[[User:Eric Martz/Proteopedia:Introduction]] | ||
*[[Proteopedia:Languages]] | *[[Proteopedia:Languages]] | ||
*[[Proteopedia:Namespaces]] | *[[Proteopedia:Namespaces]] | ||
*[[Proteopedia:News]] | *[[Proteopedia:News]] | ||
*[[Proteopedia:Overview]] <- [[Introduction to Proteopedia]] | |||
*[[Proteopedia:Policy]] | *[[Proteopedia:Policy]] | ||
*[[:Proteopedia:Problems]] | *[[:Proteopedia:Problems]] | ||